Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy.
Gastric Cancer
; 25(4): 741-750, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35661944
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
B7-H1 Antigen
/
Immunotherapy
Type of study:
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Gastric Cancer
Journal subject:
GASTROENTEROLOGIA
/
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
Singapore
Country of publication:
Japan